These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15632341)

  • 1. New avenues of exploration for erythropoietin.
    Maiese K; Li F; Chong ZZ
    JAMA; 2005 Jan; 293(1):90-5. PubMed ID: 15632341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin in the brain: can the promise to protect be fulfilled?
    Maiese K; Li F; Chong ZZ
    Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin.
    Chong ZZ; Kang JQ; Maiese K
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):320-30. PubMed ID: 12621307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and the heart: physiological effects and the therapeutic perspective.
    Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G
    Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and the vascular wall: the controversy continues.
    Jelkmann W; Elliott S
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23 Suppl 1():S37-43. PubMed ID: 22682530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?
    Latini R; Brines M; Fiordaliso F
    Heart Fail Rev; 2008 Dec; 13(4):415-23. PubMed ID: 18236153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular protection by erythropoietin: new therapeutic implications?
    Joyeux-Faure M
    J Pharmacol Exp Ther; 2007 Dec; 323(3):759-62. PubMed ID: 17717190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.
    Li F; Chong ZZ; Maiese K
    Neurosignals; 2004; 13(6):265-89. PubMed ID: 15627815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways.
    Chong ZZ; Kang JQ; Maiese K
    Br J Pharmacol; 2003 Mar; 138(6):1107-18. PubMed ID: 12684267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and plasticity: role of erythropoietin in vascular systems.
    Chong ZZ; Kang JQ; Maiese K
    J Hematother Stem Cell Res; 2002 Dec; 11(6):863-71. PubMed ID: 12590701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidative effects of erythropoietin.
    Katavetin P; Tungsanga K; Eiam-Ong S; Nangaku M
    Kidney Int Suppl; 2007 Nov; (107):S10-5. PubMed ID: 17943138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and cerebral vascular protection: role of nitric oxide.
    Santhanam AV; Katusic ZS
    Acta Pharmacol Sin; 2006 Nov; 27(11):1389-94. PubMed ID: 17049112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.
    Chong ZZ; Lin SH; Kang JQ; Maiese K
    J Neurosci Res; 2003 Mar; 71(5):659-69. PubMed ID: 12584724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
    Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD
    Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin: new horizon in cardiovascular medicine.
    Koul D; Dhar S; Chen-Scarabelli C; Guglin M; Scarabelli TM
    Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):5-12. PubMed ID: 18221097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raves and risks for erythropoietin.
    Maiese K; Chong ZZ; Shang YC
    Cytokine Growth Factor Rev; 2008 Apr; 19(2):145-55. PubMed ID: 18299246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin, erythropoiesis and beyond.
    Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.
    Maiese K; Chong ZZ; Li F; Shang YC
    Prog Neurobiol; 2008 Jun; 85(2):194-213. PubMed ID: 18396368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine.
    Buemi M; Nostro L; Romeo A; Giacobbe MS; Aloisi C; Sturiale A; Bolignano D; Allegra A; Grasso G; Frisina N
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):299-311. PubMed ID: 17073607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.